Explore all pages
Current public live-site pages, retained for this alternative review. English and existing Chinese pages are listed separately. The scorecard opens the current live forty-question, nine-area version.
English services, company & legal
- Alternative homepage — draft
- Clinic launch consulting in Dubai
- The Dubai Clinic Growth System
- Dubai Longevity Authority readiness: what clinics must prepare
- Dr Denita Lim, Founder
- Fractional managing director for clinics in Dubai
- Longevity clinic insights, Dubai and UAE
- Clinic operations journals and templates
- Links
- How to open a longevity clinic in Dubai
- Patient experience training for clinics in Dubai
- Privacy Notice
- Clinic Readiness Diagnostic
- Refund Policy
- Terms & Conditions
- Track record
- Longevity medicine training for clinicians in Dubai
Published field notes
- 5 emerging trends that will redefine preventive healthcare
- How clinic operators stay ahead of the curve
- Keeping a clinic’s core integrity when leadership pivots
- Managing UHNW and VIP patients in healthcare
- Running a start-up high-end longevity clinic
- The people who keep a clinic running
- How clinicians can engage with clinic operations
- Commissioning clinics: why no two are ever the same
- East meets west in longevity: finding ikigai
- Everyone claims Medicine 3.0. Almost nobody can prove it
- From hospitals to hospitality in longevity care
- Innovation to governance: a defining moment for the UAE
- From reactive to personalised: the evolution of medicine
- The many faces of longevity clinics
- The next wave in longevity: brain, fertility and neuro
- Functional and regenerative medicine: conditions for renewal
- What the east already knows about longevity
- Why are longevity packages so expensive?
- Why there’s still no perfect EMR for longevity medicine
Training courses & lesson pages
- Chelation therapy
- Chelation therapy: Adverse events and escalation
- Chelation therapy: Consent points
- Chelation therapy: Contraindications and pre-treatment checks
- Chelation therapy: Onsite unit
- Chelation therapy: Recognised indications
- Chelation therapy: Safety protocol and monitoring
- Chelation therapy: Sources
- Chelation therapy: What it is and the evidence status
- Extracorporeal blood oxygenation and ozonation (EBOO)
- Eboo: Adverse events and escalation
- Eboo: Consent points
- Eboo: Contraindications and pre-treatment checks
- Eboo: Onsite unit
- Eboo: Recognised indications
- Eboo: Safety protocol and monitoring
- Eboo: Sources
- Eboo: What it is and the evidence status
- Healthspan and longevity foundations
- Healthspan foundations: Assessment frameworks
- Healthspan foundations: The evidence base
- Healthspan foundations: Live online teaching
- Healthspan foundations: Sources
- Healthspan foundations: How a longevity pathway is structured, documented and reviewed
- Intermittent hypoxic-hyperoxic training (IHHT)
- Ihht: Adverse events and escalation
- Ihht: Consent points
- Ihht: Contraindications and pre-treatment checks
- Ihht: Onsite unit
- Ihht: Recognised indications
- Ihht: Safety protocol and monitoring
- Ihht: Sources
- Ihht: What it is and the evidence status
- Lab testing and biomarker interpretation
- Lab testing biomarkers: Communicating results to patients
- Lab testing biomarkers: Interpreting trends
- Lab testing biomarkers: Live online teaching
- Lab testing biomarkers: Panel selection
- Lab testing biomarkers: Reference ranges versus optimal ranges
- Lab testing biomarkers: Sources
- The ritual: concierge experience
- Luxury patient experience: Privacy and complaint recovery
- Luxury patient experience: Service philosophy
- Luxury patient experience: Sources
- Luxury patient experience: VIP protocol
- Injectable ozone
- Ozone injectable: Adverse events and escalation
- Ozone injectable: Consent points
- Ozone injectable: Contraindications and pre-treatment checks
- Ozone injectable: Onsite unit
- Ozone injectable: Recognised indications
- Ozone injectable: Safety protocol and monitoring
- Ozone injectable: Sources
- Ozone injectable: What it is and the evidence status
- IV ozone
- Ozone iv: Adverse events and escalation
- Ozone iv: Consent points
- Ozone iv: Contraindications and pre-treatment checks
- Ozone iv: Onsite unit
- Ozone iv: Recognised indications
- Ozone iv: Safety protocol and monitoring
- Ozone iv: Sources
- Ozone iv: What it is and the evidence status
- Therapeutic plasmapheresis
- Therapeutic plasmapheresis: Adverse events and escalation
- Therapeutic plasmapheresis: Consent points
- Therapeutic plasmapheresis: Contraindications and pre-treatment checks
- Therapeutic plasmapheresis: Onsite unit
- Therapeutic plasmapheresis: Recognised indications
- Therapeutic plasmapheresis: Safety protocol and monitoring
- Therapeutic plasmapheresis: Sources
- Therapeutic plasmapheresis: What it is and the evidence status